Health
A Cancer Treatment That Could Help Some Patients Avoid Surgery
A new U.S. approval for dostarlimab offers an alternative for a specific group of rectal-cancer patients, while longer follow-up remains essential.
Read Full Story
The story behind the headline.
A new U.S. approval for dostarlimab offers an alternative for a specific group of rectal-cancer patients, while longer follow-up remains essential.
Read Full StoryNews That Matters
Read Highlight Review in a dedicated app window.
Home screen access · Personalized news · Your account
We use essential cookies to keep Highlight Review working. Optional analytics, personalization and advertising are used only with your permission.
Choose which optional categories you want to allow. You can change this choice anytime.